Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- European regulators approve breast cancer drug: GSK
- LONDON AFP — British pharmaceutical firm GlaxoSmithKline said on Thursday that European regulators had given marketing approval for its tablet breast cancer drug Tyverb. "GlaxoSmithKline announced today that the European Commission has granted a conditional marketing authorisation for Tyverb ... for all 27 European Union member states," GSK said...
- Research articles 2008-06-12
- UK Nixes GSK Cancer Drug; Politics of Pricing Revealed
- The UK's drug pricing control board, NICE, which says yea or nay to drugs that the National Health Service can use, said Tuesday it would not approve Tyverb for use on British patients. The interim decision reveals how political the world of cancer has become, with science taking a back...
- Blog posts 2008-10-15
- << Previous
- page 1 of 1
- Next >>